Talis Biomedical Stock (NASDAQ: TLIS) stock price, news, charts, stock research, profile.
Open | $4.27 |
Close | $4.52 |
Volume / Avg. | 24.70K / 17.51K |
Day Range | $4.27 - $4.64 |
52 Wk Range | 3.75 - 9.60 |
Market Cap | $7.11M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 1.83% |
Days to Cover | 5.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Talis Biomedical (NASDAQ:TLIS) through any online brokerage.
Other companies in Talis Biomedical’s space includes: Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO), Autonomix Medical (NASDAQ:AMIX) and QT Imaging Holdings (NASDAQ:QTI).
Talis Biomedical has a consensus price target of $4.50.
The stock price for Talis Biomedical (NASDAQ: TLIS) is $3.9 last updated August 23, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Talis Biomedical.
Talis Biomedical’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Talis Biomedical.
Talis Biomedical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.